ArticleBreast cancer research and treatment2019

Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.

Jangsoon Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.